Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis

Figure 13

Differences in immunophenotype scores between low-risk and high-risk groups. (a–d) Immunotherapy analysis violin chart.

(a)

(b)

(c)

(d)